UK Medical Cannabis Clinics Compared: Sapphire, Lyphe, Mamedica and Releaf

If you want to access medical cannabis legally in the United Kingdom, you face an immediate obstacle: the NHS almost never prescribes it. Private clinics have stepped in to fill that gap and have grown into a multimillion-pound industry.

Why the NHS Rarely Prescribes Medical Cannabis

Since November 2018, medical cannabis has technically been legal in the UK. In practice, this almost never happens:

• NICE guidelines: The National Institute for Health and Care Excellence recommends cannabis only for three specific indications at NHS level: childhood epilepsy, chemotherapy-induced nausea, and MS spasticity.
• Clinician caution: Many NHS specialists remain uncertain due to sparse guidelines, historic stigma and limited training.
• Budget pressures: NHS trusts avoid costly therapies where the evidence base is still developing.

Result: fewer than ten NHS patients across the entire UK have ever received a cannabis prescription, set against an estimated 1.8 million illegal users who could potentially benefit from medical treatment.

How Private Clinics Work

1. Online registration: Complete a form covering diagnoses, medication history and current symptoms.
2. Initial consultation: A video call or in-person appointment with a specialist, often a neurologist or pain-medicine physician.
3. Prescription: If suitable, the clinician issues a private prescription.
4. Pharmacy: The prescription is sent to a specialist pharmacy such as Sapphire Pharmacy, Boots Specialist or Curaleaf Pharmacy.
5. Delivery: Your medicine is delivered to your door or collected from the pharmacy.

The Major Clinics Compared

Sapphire Medical Clinics

Sapphire is widely regarded as the pioneer, one of the first clinics to open after the 2018 legalisation. Multiple physical locations in London, Birmingham and Bristol, deep clinical expertise and a broad product portfolio. Consultation fees sit at the higher end of the market.

• Initial consultation: approximately £150–£200
• Follow-up appointments: approximately £50–£100
• Product costs: £150–£350 per month

Lyphe

Online-first clinic focused on cost efficiency. Entirely digital, the largest UK provider by patient numbers. Fast appointments, often within a week, and integrated pharmacy dispensing.

• Initial consultation: from £99
• Monthly product costs: £150–£280

Mamedica

Patient-centred alternative with a wide product range. Known for clear communication, access to diverse cultivars and a supportive patient community.

• Initial consultation: approximately £100–£150
• Broad portfolio: flower, oils, capsules

Releaf UK

Fully telemedicine-based and specialised in chronic pain and mental health including anxiety and PTSD. NHS-experienced clinicians with fast digital processing and well-regarded aftercare.

• Focus: pain, anxiety, PTSD, sleep disorders
• Costs similar to Lyphe

Cost Overview

Which Clinic Is Right for Whom?

• New patients without experience: Lyphe or Mamedica — affordable, fast and clearly explained.
• Complex conditions: Sapphire — greater expertise and more personalised care.
• Pain and mental health: Releaf UK — specialisation pays off.
• Tight budget: Lyphe — lowest entry costs.

Summary

Private cannabis clinics in the UK represent the only realistic route to legal treatment for hundreds of thousands of patients. The market has matured and professionalised — differences between providers mainly come down to price, digital maturity and clinical specialisation.

Further reading: Medical Cannabis UK — Complete Guide | Patient Information | Cannabis Law UK Explained